HealthCor Management’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History

HealthCor Management’s Portfolio EUCRW Stock Details EUCRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$4.34K	Hold	78,059	–	–	﹤0.01%	21
2022 Q3	$2K	Hold	78,059	–	–	﹤0.01%	57
2022 Q2	$2K	Hold	78,059	–	–	﹤0.01%	58
2022 Q1	$15K	Hold	78,059	–	–	﹤0.01%	64
2021 Q4	$45K	Buy	+78,059	New	+$57.4K	﹤0.01%	68

Other funds holding EUCRW

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

HealthCor Management's EUCRW Position: Q4 2022 in Review

HealthCor Management held its Eucrates Biomedical Acquisition Corp. Warrant (EUCRW) position steady in Q4 2022 at 78,059 shares worth $4.34K. The position accounts for ﹤0.01% of the portfolio, ranked #21.

HealthCor Management first reported a position in EUCRW in Q4 2021 and has held it in 5 quarters since. The position peaked at $45K in Q4 2021. 25 funds tracked by Wall St. Rank hold EUCRW as of Q4 2022.

HealthCor Management held 78,059 shares of Eucrates Biomedical Acquisition Corp. Warrant worth $4.34K as of Q4 2022.
HealthCor Management left its Eucrates Biomedical Acquisition Corp. Warrant share count unchanged in Q4 2022.
Eucrates Biomedical Acquisition Corp. Warrant made up ﹤0.01% of HealthCor Management's portfolio in Q4 2022, its #21 holding.
HealthCor Management first reported a position in Eucrates Biomedical Acquisition Corp. Warrant in Q4 2021 and has held it in 5 quarters since.
HealthCor Management's Eucrates Biomedical Acquisition Corp. Warrant position peaked at $45K in Q4 2021.
25 funds tracked by Wall St. Rank held Eucrates Biomedical Acquisition Corp. Warrant as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.